Although the short-term outcome of patients treated by thrombolysis du
ring the acute phase of myocardial infarction is now well known, data
concerning the repercussions of the coronary accident on smoking are l
ess clearly established. This aspect is particularly important, as ces
sation of smoking is one of the most effective measures in the context
of secondary prevention, with an excellent cost-benefit ratio. Betwee
n 1985 and 1991, 218 consecutive patients underwent thrombolysis for m
yocardial infarction. With a follow-up of 35 +/- 20 months, 11.5% of p
atients have died, including 6% while in hospital. A questionnaire was
sent to 193 surviving patients with a response rate of 97.4%. 27.3% o
f patients continued to smoke after the myocardial infarction. Smoking
patients were younger (p=0.001) and had generally returned to work (p
=0.05). Continuation of smoking was not influenced by either the paten
cy of the artery or the type of revascularization, and was not correla
ted with residual symptoms. The frequency of arrhythmias during the ac
ute phase was not related to previous smoking. On the other hand, smok
ing patients who survived after an infarction appear to quit smoking t
wice as frequently when they had experienced a cardiac arrhythmia duri
ng the acute phase of the infarction (p=0.005), as confirmed by multiv
ariate analysis. Can the ''stress'' induced by the arrhythmia, possibl
y combined with the doctor's reactive anxiety explain cessation of smo
king in these patients? If so, it would open new horizons in terms of
secondary prevention of myocardial infarction.